2012
Apotex v. USA (III) Apotex Holdings Inc. and Apotex Inc. v. United States of America (III) (ICSID Case No. ARB(AF)/12/1)
United States of America
Canada
Indirect ownership and control of an American-based Apotex affiliate engaged in the distribution of generic drugs.
Claims arising out of alleged injuries from "Import Alerts" issued by the U.S. Food and Drug Administration concerning two of Apotex’s Canadian manufacturing facilities.
Secondary: C - Manufacturing
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
ICSID AF (ICSID Additional Facility)
ICSID (International Centre for Settlement of Investment Disputes)
Veeder, V. V.
Rowley, J. W.
Crook, J. R.
Decided in favour of State
1500.00 mln USD
Data not available
Fair and equitable treatment/Minimum standard of treatment, including denial of justice claims

National treatment

Most-favoured nation treatment
None - all claims dismissed at the merits stage
None